Sympathetic nervous system and the kidney in hypertension

Long-term control of arterial pressure has been attributed to the kidney by virtue of its ability to couple the regulation of blood volume to the maintenance of sodium and water balance by the mechanisms of pressure natriuresis and diuresis. In the presence of a defect in renal excretory function, hypertension arises as the consequence of the need for an increase in arterial pressure to offset the abnormal pressure natriuresis and diuresis mechanisms, and to maintain sodium and water balance. There is growing evidence that an important cause of the defect in renal excretory function in hypertension is an increase in renal sympathetic nerve activity (RSNA). First, increased RSNA is found in animal models of hypertension and hypertensive humans. Second, renal denervation prevents or alleviates hypertension in virtually all animal models of hypertension. Finally, increased RSNA results in reduced renal excretory function by virtue of effects on the renal vasculature, the tubules, and the juxtaglomerular granular cells. The increase in RSNA is of central nervous system origin, with one of the stimuli being the action of angiotensin II, probably of central origin. By acting on brain stem nuclei that are important in the control of peripheral sympathetic vasomotor tone (e.g. rostral ventrolateral medulla), angiotensin II increases the basal level of RSNA and impairs its arterial baroreflex regulation. Therefore, the renal sympathetic nerves may serve as the link between central sympathetic nervous system regulatory sites and the kidney in contributing to the renal excretory defect in the development of hypertension.

[1]  D. Mion,et al.  Mild chronic renal insufficiency induces sympathetic overactivity , 2001, Journal of Human Hypertension.

[2]  G. Mancia,et al.  Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. , 1997, Circulation.

[3]  P. Blankestijn,et al.  Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. , 1999, The New England journal of medicine.

[4]  M. Koss,et al.  A limited renal injury may cause a permanent form of neurogenic hypertension. , 1998, American journal of hypertension.

[5]  V. Campese,et al.  Renal afferent denervation prevents hypertension in rats with chronic renal failure. , 1995, Hypertension.

[6]  G. Dibona,et al.  Sodium Intake Influences Hemodynamic and Neural Responses to Angiotensin Receptor Blockade in Rostral Ventrolateral Medulla , 2001, Hypertension.

[7]  G. Jennings,et al.  Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension , 2000, Hypertension.

[8]  M. Elam,et al.  Differentiated Response of the Sympathetic Nervous System to Angiotensin-Converting Enzyme Inhibition in Hypertension , 2000, Hypertension.

[9]  E A Anderson,et al.  Elevated Sympathetic Nerve Activity in Borderline Hypertensive Humans Evidence From Direct Intraneural Recordings , 1989, Hypertension.

[10]  F. Quartieri,et al.  Norepinephrine Reuptake Is Impaired in Skeletal Muscle of Hypertensive Rats In Vivo , 2001, Hypertension.

[11]  W. Anderson,et al.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.